NT-I7

· NeoImmuneTech

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for NT-I7, covering 2024-03-05 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Results: Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy [Phase 1]